NCT05838898

Brief Summary

.1. corneal endothelial profile in patients with proliferative diabetic retinopathy compared to a healthy age-matched control group. 2\. The effect of the age, and duration of Diabetes on the corneal endothelium .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2022

Completed
8 months until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
29 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

May 3, 2023

Status Verified

April 1, 2023

Enrollment Period

1.6 years

First QC Date

September 9, 2022

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • To predict the effect of Diabetes on the cornea of diabetic patients

    To evaluate corneal endothelial changes in patients with Proliferative diabetic retinopathy compared to normal group of the same age and gender using Specular microscopy

    Baseline

Interventions

Non-contact Specular microscopy is a non-invasive method that allows for in vivo study of corneal endothelium.

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Image capture will be done by the same individual for all subjects. The following data will be collected and analyzed: corneal endothelial cell count, coefficient of variation, percentage of hexagonal cells and central corneal thickness.

You may qualify if:

  • patients with Type I or II Diabetes Mellitus
  • Diagnosed with proliferative diabetic retinopathy . .Intraocular pressure less than 21mmHg.
  • Healthy controls:
  • Healthy individuals aged 40 to 70 years of both sexes. .Intraocular pressure less than 21 mmHg.

You may not qualify if:

  • Diabetic group:
  • Associated ocular diseases that may affect the corneal endothelium such as uveitis, glaucoma, and dystrophy, prolonged CLs use.
  • Previous ocular trauma or surgery.
  • Healthy control:
  • Any systemic diseases that may affect corneal endothelium function.
  • Associated ocular diseases that may affect the corneal endothelium such as uveitis, glaucoma, and dystrophy, prolonged CLs use.
  • Previous ocular trauma , surgery ,laser or intraocular injection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Mortazavi SA, Akhlaghi M, Dehghani A, Pourazizi M, Malekahmadi M, Fazel M, Tavakoli M, Noorshargh P. Diabetic retinopathy and corneal endothelial parameters: an analytical cross-sectional study. BMC Ophthalmol. 2022 Nov 9;22(1):427. doi: 10.1186/s12886-022-02667-6.

    PMID: 36348282BACKGROUND
  • Jha A, Verma A, Alagorie AR. Association of severity of diabetic retinopathy with corneal endothelial and thickness changes in patients with diabetes mellitus. Eye (Lond). 2022 Jun;36(6):1202-1208. doi: 10.1038/s41433-021-01606-x. Epub 2021 Jun 11.

    PMID: 34117392BACKGROUND

Central Study Contacts

Marline reda, Master

CONTACT

Kamel abd el nasser, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist

Study Record Dates

First Submitted

September 9, 2022

First Posted

May 3, 2023

Study Start

June 1, 2023

Primary Completion

January 1, 2025

Study Completion

June 1, 2025

Last Updated

May 3, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share